- Description
- Specifications
Catalog #: PRV-002
Description:
Recombinant Parvovirus B19 VLP VP1/VP2 Co-Capsid produced in SF9 containing B19 capsid proteins VP1 (86,049 Dalton) and VP2 (60,839 Dalton).
Parvovirus B19 VLP VP1/VP2 is purified by proprietary chromatographic techniques.
Source:
Sf9 insect cells.
Applications:
Western blot with anti-Parvovirus B19 positive sera.
Purity:
Greater than 80.0% as determined by SDS-PAGE.
Formulation:
Parvovirus B19 VLP VP1/VP2 protein solution is supplied in 16mM Sodium phosphate pH-7.4, 120mM NaCl and 20% glycerol.
Stability:
Store at 4 °C if entire vial will be used within 2-4 weeks. Store, frozen at -20 °C for longer periods of time.
Avoid multiple freeze-thaw cycles.
Physical Appearance:
Sterile Filtered clear solution.
Immunological Functions:
1. Binds IgG-type human antibodies.
2. Immunodot test with positive/negative sera.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
